194 related articles for article (PubMed ID: 10500832)
21. Intracellular disposition of methotrexate in acute lymphoblastic leukemia in children.
de Beaumais TA; Jacqz-Aigrain E
Curr Drug Metab; 2012 Jul; 13(6):822-34. PubMed ID: 22571483
[TBL] [Abstract][Full Text] [Related]
22. Effects of overexpression of gamma-Glutamyl hydrolase on methotrexate metabolism and resistance.
Cole PD; Kamen BA; Gorlick R; Banerjee D; Smith AK; Magill E; Bertino JR
Cancer Res; 2001 Jun; 61(11):4599-604. PubMed ID: 11389096
[TBL] [Abstract][Full Text] [Related]
23. Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia.
Barredo JC; Synold TW; Laver J; Relling MV; Pui CH; Priest DG; Evans WE
Blood; 1994 Jul; 84(2):564-9. PubMed ID: 7517720
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of resistance to methotrexate in childhood acute lymphoblastic leukemia: circumvention of thymidylate synthase inhibition.
Weigand M; Frei E; Graf N; Buchholz B; Wolfrom C; Breuer A; Wiessler M
J Cancer Res Clin Oncol; 1999; 125(8-9):513-9. PubMed ID: 10480345
[TBL] [Abstract][Full Text] [Related]
25. Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia.
Stark M; Wichman C; Avivi I; Assaraf YG
Blood; 2009 Apr; 113(18):4362-9. PubMed ID: 19131550
[TBL] [Abstract][Full Text] [Related]
26. Disparate mechanisms of antifolate resistance provoked by methotrexate and its metabolite 7-hydroxymethotrexate in leukemia cells: implications for efficacy of methotrexate therapy.
Fotoohi K; Jansen G; Assaraf YG; Rothem L; Stark M; Kathmann I; Gregorczyk J; Peters GJ; Albertioni F
Blood; 2004 Dec; 104(13):4194-201. PubMed ID: 15308564
[TBL] [Abstract][Full Text] [Related]
27. A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemia.
Rots MG; Pieters R; Jansen G; Kaspers GJ; Van Zantwijk CH; Noordhuis P; Voorn DA; Van Wering ER; Creutzig U; Veerman AJ; Peters GJ
Eur J Cancer; 2001 Mar; 37(4):492-8. PubMed ID: 11267859
[TBL] [Abstract][Full Text] [Related]
28. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines.
Liani E; Rothem L; Bunni MA; Smith CA; Jansen G; Assaraf YG
Int J Cancer; 2003 Feb; 103(5):587-99. PubMed ID: 12494465
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of polyglutamylation in primary central nervous system lymphoma.
Shinojima N; Fujimoto K; Makino K; Todaka K; Yamada K; Mikami Y; Oda K; Nakamura K; Jono H; Kuratsu JI; Nakamura H; Yano S; Mukasa A
Acta Neuropathol Commun; 2018 Feb; 6(1):15. PubMed ID: 29475458
[TBL] [Abstract][Full Text] [Related]
30. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
Zhao R; Babani S; Gao F; Liu L; Goldman ID
Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
[TBL] [Abstract][Full Text] [Related]
31. Development and Validation of a Sensitive UHPLC-MS/MS-Based Method for the Analysis of Folylpolyglutamate Synthetase Enzymatic Activity in Peripheral Blood Mononuclear Cells: Application in Rheumatoid Arthritis and Leukemia Patients.
Muller IB; Lin M; Struys EA; Heydari P; Hebing RCF; Nurmohamed MT; van der Laken C; Lems WF; Cloos J; Jansen G; de Jonge R
Ther Drug Monit; 2019 Oct; 41(5):598-606. PubMed ID: 31008996
[TBL] [Abstract][Full Text] [Related]
32. Cellular pharmacokinetic of methotrexate and its modulation by folylpolyglutamate synthetase and γ-glutamyl hydrolase in tumor cells.
Tang F; Zou L; Chen J; Meng F
PLoS One; 2024; 19(6):e0302663. PubMed ID: 38833640
[TBL] [Abstract][Full Text] [Related]
33. Methotrexate intracellular disposition in acute lymphoblastic leukemia: a mathematical model of gamma-glutamyl hydrolase activity.
Panetta JC; Wall A; Pui CH; Relling MV; Evans WE
Clin Cancer Res; 2002 Jul; 8(7):2423-9. PubMed ID: 12114448
[TBL] [Abstract][Full Text] [Related]
34. Acute monocytic leukemia: a myeloid leukemia subset that may be sensitive to methotrexate.
Göker E; Kheradpour A; Waltham M; Banerjee D; Tong WP; Elisseyeff Y; Bertino JR
Leukemia; 1995 Feb; 9(2):274-6. PubMed ID: 7532768
[TBL] [Abstract][Full Text] [Related]
35. Differences in folylpolyglutamate synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicity.
Galpin AJ; Schuetz JD; Masson E; Yanishevski Y; Synold TW; Barredo JC; Pui CH; Relling MV; Evans WE
Mol Pharmacol; 1997 Jul; 52(1):155-63. PubMed ID: 9224825
[TBL] [Abstract][Full Text] [Related]
36. In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile.
Sorich MJ; Pottier N; Pei D; Yang W; Kager L; Stocco G; Cheng C; Panetta JC; Pui CH; Relling MV; Cheok MH; Evans WE
PLoS Med; 2008 Apr; 5(4):e83. PubMed ID: 18416598
[TBL] [Abstract][Full Text] [Related]
37. Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia.
Matherly LH; Taub JW; Ravindranath Y; Proefke SA; Wong SC; Gimotty P; Buck S; Wright JE; Rosowsky A
Blood; 1995 Jan; 85(2):500-9. PubMed ID: 7812005
[TBL] [Abstract][Full Text] [Related]
38. Histone deacetylase inhibitors induce FPGS mRNA expression and intracellular accumulation of long-chain methotrexate polyglutamates in childhood acute lymphoblastic leukemia: implications for combination therapy.
Leclerc GJ; Mou C; Leclerc GM; Mian AM; Barredo JC
Leukemia; 2010 Mar; 24(3):552-62. PubMed ID: 20072153
[TBL] [Abstract][Full Text] [Related]
39. Role of the E45K-reduced folate carrier gene mutation in methotrexate resistance in human leukemia cells.
Gifford AJ; Haber M; Witt TL; Whetstine JR; Taub JW; Matherly LH; Norris MD
Leukemia; 2002 Dec; 16(12):2379-87. PubMed ID: 12454742
[TBL] [Abstract][Full Text] [Related]
40. Evidence for negative feedback of extracellular methotrexate on blasts of acute lymphoblastic leukemia in vitro.
Hum MC; Smith AK; Lark RH; Winick NJ; Kamen BA
Pharmacotherapy; 1997; 17(6):1260-6. PubMed ID: 9399609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
